REGN vs BMY — Performance Comparison
Side-by-side percent change for Regeneron Pharmaceuticals, Inc. (REGN), Bristol-Myers Squibb Company (BMY) across every preset interval.
Over the past year, BMY is up 23.39% versus REGN up 19.50% — BMY ahead by 3.89%. Over the past 30 days, BMY is down 2.36% and REGN is down 7.28%. REGN trades at $699.07; BMY at $56.53.
| Ticker | Price | 1D | 3D | 7D | 30D | 90D | YTD | 6M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|---|---|
| REGN Regeneron Pharmaceuticals, Inc. | $699.07 | -1.94% | -3.36% | -2.21% | -7.28% | -12.96% | -9.43% | +0.80% | +19.50% | -5.82% ★ | +33.48% ★ |
| BMY Bristol-Myers Squibb Company | $56.53 | -0.43% ★ | +0.13% ★ | +0.65% ★ | -2.36% ★ | -6.94% ★ | +4.79% ★ | +21.17% ★ | +23.39% ★ | -15.66% | -13.65% |
Want to zoom in?
Open the interactive Compare tool to overlay these tickers on a normalized chart, pin any two dates to see the exact return between them, and pick a custom interval.
Open in interactive CompareEach ticker's detail page
REGNRegeneron Pharmaceuticals, Inc.
$699.07-1.94% today
BMYBristol-Myers Squibb Company
$56.53-0.43% today